Page 115 - 201901
P. 115

第 36 卷第 1 期                             精   细   化   工                                  Vol.36, No.1
             201 9 年 1 月                             FINE CHEMICALS                                 Jan.  2019


              医药与日化原料
                                      RDEA3170 合成工艺优化



                                               *
                            胡   旭,尹传奇 ,杨梦然,傅   晶,吴   莉,冯权武
                                   (武汉工程大学  化学与环境工程学院,湖北  武汉  430205)


                 摘要:以 1,4-二溴萘为起始原料,经溴-镁交换、羧基化、酰胺化和脱水反应,优化了 4-溴-1-萘甲腈(Ⅳ)合成
                 方法。通过连续反应法,以 Pd(PPh 3 ) 2 Cl 2 催化实现了 4-溴-1-萘甲腈的 Miyaura 硼烷基化及其产物(4-氰基萘-1-基)
                 硼酸频那醇酯(Ⅴ)与 2-((3-溴吡啶-4-基)硫)-2-甲基丙酸乙酯(Ⅰ)的 Suzuki 偶联,得到 2-((3-(4-氰基萘-1-基)吡
                 啶-4-基)硫)-2-甲基丙酸乙酯(Ⅵ)。连续反应的最佳工艺条件为:n(联硼酸频那醇酯)∶n(Ⅳ)∶n(Ⅰ)∶n
                 〔Pd(PPh 3 ) 2 Cl 2 〕∶n(KOAc)∶n(K 2 CO 3 )=1.1∶1∶1∶0.06∶3∶3;KOAc 和 K 2 CO 3 分别作为 Miyaura 硼烷基化和
                 Suzuki 偶联反应的碱依次加入,相应的反应温度分别为 80 和 110 ℃,反应时间分别为 2 和 12 h。化合物Ⅵ水解
                                                                                 1
                                                                                          13
                 得到产品 RDEA3170〔2-((3-(4-氰基萘-1-基)吡啶-4-基)硫)-2-甲基丙酸〕,其结构经 HNMR 和 CNMR 表征。该
                 合成工艺 RDEA3170 的总收率达到 42%,适合工业化生产。
                 关键词:4-溴-1-萘甲腈;溴-镁交换反应;连续反应法;Suzuki 偶联;RDEA3170;合成工艺优化;医药原料
                 中图分类号:TQ460.31      文献标识码:A     文章编号:1003-5214 (2019) 01-0101-05



                                 Synthetic Process Optimization of RDEA3170

                                               *
                           HU Xu, YIN Chuan-qi , YANG Meng-ran, FU Jing, WU Li, FENG Quan-wu
                  (School of Chemistry and Environmental Engineering, Wuhan Institute of Technology, Wuhan 430205, Hubei, China)

                 Abstract: A new method for the synthesis of 4-bromo-1-naphthonitrile (Ⅳ) from 1,4-dibromonaphthalene
                 was conducted by bromo-magnesium exchange reaction, carboxylation, amidation and dehydration. In the
                 presence  of catalyst Pd(PPh 3) 2Cl 2, the Miyaura  borylation reaction enabled the synthesis of  4-(4,4,5,5-
                 tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthonitrile (Ⅴ)  by  cross-coupling of bis (pinacolato) diboron
                 (BPIN) 2 with 4-bromo-1-naphthonitrile and the Suzuki coupling reaction  between intermediate  Ⅴ with
                 ethyl 2-(3-bromopyridin-4-ylthio)-2-methylpropanoate (Ⅰ) led to ethyl 2-(3-(4-cyanonaphthalen-1-yl) pyridin-
                 4-ylthio)-2-methylpropanoate (Ⅵ) by continuous reaction process. The optimum conditions were as follows:
                 n[(BPIN) 2]∶n(Ⅳ)∶n(Ⅰ)∶n[Pd(PPh 3) 2Cl 2]∶n(KOAc)∶n(K 2CO 3)=1.1∶1∶1∶0.06∶3∶3, for  the
                 Miyaura borylation, KOAc used as base, reaction temperature 80 ℃, reaction time 2 h, but for the Suzuki
                 coupling, K 2CO 3  used  as base,  reaction temperature 110 ℃, reaction time 12 h. The  final  product
                 RDEA3170 [2-(3-(4-cyanonaphthalen-1-yl)pyridin-2-ylthio)-2-methylpropanoic  acid]  was obtained by
                                                          1
                                                                     13
                 hydrolysis of compound  Ⅵ  and characterized by  H NMR and  C NMR. The overall yield of RDEA3170
                 was up to 42%. This synthesis process is suitable for industrial production.
                 Key words: 4-bromo-1-naphthonitrile; bromo-magnesium exchange reaction; continuous reaction process;
                 Suzuki coupling; RDEA3170; synthetic process optimization; drug materials
                 Foundation items: Key Project  of  Hubei  Provincial Department of  Education (D20141510); Project of
                 Hubei Provincial Department of Education (B2017053)


                                                                                     [2]
                                                                                                          [3]
                 RDEA3170,化学名称为 2-((3-(4-氰基萘-1-基)              比第一代抑制剂 Lesinurad 药效更强,选择性更高 。
            吡啶-4-基)硫)-2-甲基丙酸,是第二代尿酸转运体 1                       Ⅰ期临床研究显示,40 mg  RDEA3170 能使健康志
                                                                                                         [4]
                                                        [1]
            (URAT1)抑制剂,能选择性地抑制尿酸重吸收 ,                          愿者血尿酸平均下降超过 60%,并可持续 36 h ,

                 收稿日期:2018-05-05;  定用日期:2018-07-16; DOI: 10.13550/j.jxhg.20180321
                 基金项目:湖北省教育厅重点项目(D20141510);湖北省教育厅项目(B2017053)
                 作者简介:胡   旭(1985—),男,硕士生。联系人:尹传奇(1966—),男,博士,教授,E-mail:zhyfyin@126.com。
   110   111   112   113   114   115   116   117   118   119   120